173 related articles for article (PubMed ID: 32782796)
1. Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women.
Tong Y; Tonui P; Ermel A; Orang'o O; Wong N; Titus M; Kiptoo S; Muthoka K; Loehrer PJ; Brown DR
SAGE Open Med; 2020; 8():2050312120945138. PubMed ID: 32782796
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women.
Ermel A; Tonui P; Titus M; Tong Y; Wong N; Ong'echa J; Muthoka K; Kiptoo S; Moormann A; Hogan J; Mwangi A; Cu-Uvin S; Loehrer PJ; Orang'o O; Brown D
BMC Infect Dis; 2019 Apr; 19(1):352. PubMed ID: 31029097
[TBL] [Abstract][Full Text] [Related]
3. Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV.
Ermel A; Tong Y; Tonui P; Orang'o O; Muthoka K; Wong N; Manai T; Kiptoo S; Loehrer PJ; Brown DR
Int J STD AIDS; 2021 Nov; 32(13):1212-1220. PubMed ID: 34233531
[TBL] [Abstract][Full Text] [Related]
4. Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study.
Tong Y; Tonui P; Orang'o O; Zhang J; Maina T; Muthoka K; Groopman J; Smith J; Madeen E; Ermel A; Loehrer P; Brown DR
BMC Infect Dis; 2023 Jun; 23(1):377. PubMed ID: 37280534
[TBL] [Abstract][Full Text] [Related]
5. Detection and Concentration of Plasma Aflatoxin is Associated with Detection of Oncogenic Human Papillomavirus in Kenyan Women.
Zhang J; Orang'o O; Tonui P; Tong Y; Maina T; Kiptoo S; Muthoka K; Groopman J; Smith J; Madeen E; Ermel A; Loehrer P; Brown DR
Open Forum Infect Dis; 2019 Sep; 6(9):. PubMed ID: 31392332
[TBL] [Abstract][Full Text] [Related]
6. Association of Plasma Aflatoxin With Persistent Detection of Oncogenic Human Papillomaviruses in Cervical Samples From Kenyan Women Enrolled in a Longitudinal Study.
Tong Y; Tonui P; Orang'o O; Zhang J; Maina T; Muthoka K; Groopman J; Smith J; Madeen E; Ermel A; Loehrer P; Brown D
Res Sq; 2023 Jan; ():. PubMed ID: 36747756
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women.
Minkoff H; Feldman J; DeHovitz J; Landesman S; Burk R
Am J Obstet Gynecol; 1998 May; 178(5):982-6. PubMed ID: 9609571
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Anal Human Papillomavirus Infection and Risk Factors among HIV-positive Patients in Tokyo, Japan.
Nagata N; Watanabe K; Nishijima T; Tadokoro K; Watanabe K; Shimbo T; Niikura R; Sekine K; Akiyama J; Teruya K; Gatanaga H; Kikuchi Y; Uemura N; Oka S
PLoS One; 2015; 10(9):e0137434. PubMed ID: 26368294
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.
Goldie SJ; Freedberg KA; Weinstein MC; Wright TC; Kuntz KM
Am J Med; 2001 Aug; 111(2):140-9. PubMed ID: 11498068
[TBL] [Abstract][Full Text] [Related]
11. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
12. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.
Hessol NA; Holly EA; Efird JT; Minkoff H; Schowalter K; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
AIDS; 2009 Jan; 23(1):59-70. PubMed ID: 19050387
[TBL] [Abstract][Full Text] [Related]
13. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women.
Hessol NA; Holly EA; Efird JT; Minkoff H; Weber KM; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
AIDS; 2013 Jul; 27(11):1743-51. PubMed ID: 23803793
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women.
Tornesello ML; Duraturo ML; Giorgi-Rossi P; Sansone M; Piccoli R; Buonaguro L; Buonaguro FM
J Gen Virol; 2008 Jun; 89(Pt 6):1380-1389. PubMed ID: 18474553
[TBL] [Abstract][Full Text] [Related]
15. Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
McClymont E; Lee M; Raboud J; Coutlée F; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Harris M; Cohen J; Yudin MH; Wobeser W; Money D
Int J Gynaecol Obstet; 2020 Jul; 150(1):108-115. PubMed ID: 32342504
[TBL] [Abstract][Full Text] [Related]
16. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
17. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
Keller MJ; Burk RD; Massad LS; Eltoum IE; Hessol NA; Castle PE; Anastos K; Xie X; Minkoff H; Xue X; D'Souza G; Flowers L; Levine AM; Colie C; Rahangdale L; Fischl MA; Palefsky JM; Strickler HD
Clin Infect Dis; 2015 Nov; 61(10):1573-81. PubMed ID: 26187020
[TBL] [Abstract][Full Text] [Related]
18. The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV/AIDS.
Tong Y; Orang'o E; Nakalembe M; Tonui P; Itsura P; Muthoka K; Titus M; Kiptoo S; Mwangi A; Ong'echa J; Tonui R; Odongo B; Mpamani C; Rosen B; Moormann A; Cu-Uvin S; Bailey JA; Oduor CI; Ermel A; Yiannoutsos C; Musick B; Sang E; Ngeresa A; Banturaki G; Kiragga A; Zhang J; Song Y; Chintala S; Katzenellenbogen R; Loehrer P; Brown DR
Ann Med; 2022 Dec; 54(1):1202-1211. PubMed ID: 35521812
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.
Beachler DC; Sugar EA; Margolick JB; Weber KM; Strickler HD; Wiley DJ; Cranston RD; Burk RD; Minkoff H; Reddy S; Xiao W; Guo Y; Gillison ML; D'Souza G
Am J Epidemiol; 2015 Jan; 181(1):40-53. PubMed ID: 25480823
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding.
Theiler RN; Farr SL; Karon JM; Paramsothy P; Viscidi R; Duerr A; Cu-Uvin S; Sobel J; Shah K; Klein RS; Jamieson DJ
Obstet Gynecol; 2010 Jun; 115(6):1150-1158. PubMed ID: 20502284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
